Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Holst

Showing results (81-90 of 1,570) with videos related to

Pageof 157
Sort By:
Annales Chirurgiae Et Gynaecologiae|January 1, 1985
Conservative treatment of ureteric stones. Ureteric stones--surgical interventionK Ala-Kulju, P Nummi, J Holst
Maturitas|April 1, 1987
Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaintsJ Holst, S Cajander, B von Schoultz
European Journal of Clinical Investigation|January 1, 1997
Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy manA Shalev, J J Holst, U Keller
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitusB Ahrén, H Larsson, J J Holst
The American Journal of Physiology|November 14, 1998
Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflowA Wettergren, M Wøjdemann, J J Holst
Diabetes|May 1, 1993
Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishableC Orskov, A Wettergren, J J Holst
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1983
Cellular morphometric analysis of the postmenopausal endometrium during treatment with percutaneous estradiol-17 beta with and without oral gestagenJ Holst, S Cajander, B von Schoultz
British Journal of Obstetrics and Gynaecology|October 1, 1984
Serum levels of unbound 17 beta-oestradiol during oral and percutaneous postmenopausal replacement therapyB Nilsson, J Holst, B von Schoultz
Peptides|July 15, 1998
The inhibitory effect of glucagon-like peptide-1 (7-36)amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36)amideA Wettergren, M Wøjdemann, J J Holst
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1987
Serum estrogen levels after topic application of estradiol-17 beta on two different cutaneous areasJ Holst, K Carlström, B von Schoultz
Pageof 157

Showing results (81-90 of 1,570) with videos related to

Sort By:
Pageof 157
Annales Chirurgiae Et Gynaecologiae|January 1, 1985
Conservative treatment of ureteric stones. Ureteric stones--surgical interventionK Ala-Kulju, P Nummi, J Holst
Maturitas|April 1, 1987
Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaintsJ Holst, S Cajander, B von Schoultz
European Journal of Clinical Investigation|January 1, 1997
Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy manA Shalev, J J Holst, U Keller
The Journal of Clinical Endocrinology and Metabolism|February 1, 1997
Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitusB Ahrén, H Larsson, J J Holst
The American Journal of Physiology|November 14, 1998
Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflowA Wettergren, M Wøjdemann, J J Holst
Diabetes|May 1, 1993
Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishableC Orskov, A Wettergren, J J Holst
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1983
Cellular morphometric analysis of the postmenopausal endometrium during treatment with percutaneous estradiol-17 beta with and without oral gestagenJ Holst, S Cajander, B von Schoultz
British Journal of Obstetrics and Gynaecology|October 1, 1984
Serum levels of unbound 17 beta-oestradiol during oral and percutaneous postmenopausal replacement therapyB Nilsson, J Holst, B von Schoultz
Peptides|July 15, 1998
The inhibitory effect of glucagon-like peptide-1 (7-36)amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36)amideA Wettergren, M Wøjdemann, J J Holst
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1987
Serum estrogen levels after topic application of estradiol-17 beta on two different cutaneous areasJ Holst, K Carlström, B von Schoultz
Pageof 157